Diabetes & EndocrinologyCONDOR trialproliferative diabetic retinopathy
Brolucizumab Outperforms Laser Therapy in Proliferative Diabetic Retinopathy: Insights from the CONDOR Trial
By MedXY|Apr 27, 2026
The CONDOR trial demonstrates brolucizumab’s superiority over panretinal photocoagulation in preserving vision and reducing disease progression in proliferative diabetic retinopathy, offering a potential shift in treatment paradigms.